For citations:
Matveev V.B., Markova A.S. Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice. Cancer Urology. 2016;12(2):84-91. https://doi.org/10.17650/1726-9776-2016-12-2-84-91
Matveev V.B., Markova A.S. Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice. Cancer Urology. 2016;12(2):84-91. https://doi.org/10.17650/1726-9776-2016-12-2-84-91